Validation of Canproj for projecting Canadian cancer incidence data

• Published in: Health promotion and chronic disease prevention in Canada 2020-09, Vol.40 (9), p.267-280
• Main Authors: Demers, Alain, Qiu, Zhenguo, Dewar, Ron, Shaw, Amanda
• Format: Article
• Language: English
• Subjects: neoplasms, forecasting, validation studies
• ISSN: 2368-738X; 2368-738X
• DOI: 10.24095/hpcdp.40.9.02

INTRODUCTIONCancer projections can provide key information to help prioritize cancer control strategies, allocate resources and evaluate current treatments and interventions. Canproj is a cancer-projection tool that builds on the Nordpred R-package by adding a selection of projection models. The objective of this project was to validate the Canproj R-package for the short-term projection of cancer rates. METHODSWe used national cancer incidence data from 1986 to 2014 from the National Cancer Incidence Reporting System and Canadian Cancer Registry. Cross-validation was used to estimate the accuracy of the projections generated by Canproj and relative bias (RB) was used as validation measure. The Canproj automatic model selection decision tree was also assessed. RESULTSFive of the six models had mean RB between 5% and 10% and median RB around 5%. For some of the cancer sites that were more difficult to project, a shorter time period improved reliability. The Nordpred model was selected 79% of the time by Canproj automatic model selection although it had the smallest RB only 24% of the time. CONCLUSIONSThe Canproj package was able to provide projections that closely matched the real data for most cancer sites.